NEW YORK, Aug 29 – Oxagen of Abingdon, UK, and Cerylid Biosciences of Melbourne, said Wednesday that they had agreed to collaborate to jointly study the genetic basis of endometriosis. 

Oxagen and Cerylid are planning to look for genes and SNPs that lead to endometriosis and to eventually find targets that will lead to new diagnostics and treatments for the disease, which is estimated to affect as many as 10 percent of women of reproductive age, the companies said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.